Previous Article | Next Article ![]()
Infection and Immunity, December 2000, p. 6561-6566, Vol. 68, No. 12
Unité d'Immunophysiologie et
Parasitisme Intracellulaire, Institut Pasteur, 75724 Paris Cedex
15, France
Received 3 May 2000/Returned for modification 14 June 2000/Accepted 6 September 2000
So far, studies of Leishmania persistence in mice have
used injections of parasites administered either intravenously in the tail vein or subcutaneously in the footpad. These routes poorly reflect
the natural conditions when the sandfly delivers metacyclic promastigotes intradermally. In this study B10D2 and BALB/c mice were
inoculated within the ear dermis with 104 Leishmania
major metacyclic promastigotes. The parasite load was monitored
by quantitative PCR in different tissues from the dermal inoculation
site to distant tissues. The two sites of multiplication and
persistence of parasites were the site of L. major
inoculation and the draining lymph node (DLN), with a different pattern
in the two mouse inbred lines. These two organs were the only sites harboring parasites 12 months postinoculation, with the DLN of BALB/c
mice harboring around 107 parasites, a stable load from
months 3 to 12. In these two sites, 8 and 12 months after inoculation,
interleukin 4 (IL-4), gamma interferon, and inducible nitric oxide
synthase transcripts parallel the parasite load while IL-10 transcript
levels remain high. In addition, at early time points until month 3, parasite DNA was also detected in distant tissues such as the
contralateral noninoculated ear or the tail skin, indicating that blood
was at least transiently disseminating the parasites. In contrast,
L. major DNA in liver, spleen, and femoral bone marrow
remained sporadic in mice of both lines. This study is discussed within
the framework of Leishmania transmission from the
vertebrate host to the sandfly vector, a complex process still poorly understood.
Leishmaniasis currently affects some
12 million individuals in 88 countries, and at least 350 million people
are exposed to the risk of the Leishmania parasite
inoculation (see the World Health Organization information at
http://www.who.int/emc/diseases/leish/leis.html). It is well
established that in Leishmania transmission areas, individuals may harbor the parasites at very low levels, without developing symptoms. These individuals, considered asymptomatic carriers, are likely to transmit the parasite to the hematophagous sandfly vector or, as shown recently, via blood transfusion
(16). Moreover, Leishmania spp. may persist
in cured hosts after drug therapy (for a review, see reference
1) and be reactivated after immunosuppression, for
instance, in human immunodeficiency virus-infected people
(3). The capacity of the parasite to establish persistent
infection as a means to achieve its transmission and hence maintenance
of its life cycle is a process common to many parasites (9,
10). Little is known on the mechanisms underlying persistence of
Leishmania parasites in their vertebrate host and
transmission to the sandflies, pool-feeder hematophagous insects
expected to recover transmissible parasites from the dermis. In a
recent study using C57BL/6 mice, described as mice resistant to
L. major, Stenger et al. (21) showed that a small
number of parasites may persist in the regional lymph node, the spleen, and in some cases also at the site of the former lesion after resolution of this primary lesion. Persistence of parasites was paralleled with a sustained expression of inducible nitric oxide synthase (iNOS), and the treatment of mice with a selective inhibitor of iNOS switches on a massive replication of the parasites in the
tissue and caused recrudescence of cutaneous leishmaniasis (21). However, the previous studies on persistence of
Leishmania in the mouse model used either intravenous
injection of the parasite in the tail vein (15) or
subcutaneous injection in the footpad (21). These routes of
injection poorly reflect what happens under natural conditions. Indeed,
when the Leishmania-carrying sandflies take their blood meal
on vertebrate hosts, they deliver metacyclic promastigotes within the
dermis. Not only the local processes driven by the parasites but also
the dissemination of the parasites within the distant mouse tissues may
depend on the route of inoculation. This was shown with L. donovani by Melby et al. (18). These authors observed
that the spleens of mice inoculated intravenously in the tail vein were
highly parasitized, as expected, while the spleens of mice infected
subcutaneously in the footpad were not. Therefore, in our laboratory, a
model of parasite inoculation within the dermis of the mouse ear has been established (5, 6) and is closer to the natural way of
infection than the above-mentioned methods. In the present study, we
have set up a model and readout assays for tracing the dissemination to
and the duration of the persistence of L. major in different
tissues of BALB/c and B10D2 mice, after inoculation of metacyclic
promastigotes within the dermis of one ear. We have developed a
quantitative PCR method for monitoring the parasite burden and load. In
long-term inoculated mice, the Leishmania organisms do
persist mainly at the site of inoculation (the ear) and its draining
lymph node. At 8 and 12 months post inoculation, we have observed that
the levels of interleukin 4 (IL-4), gamma interferon (IFN- Animals, parasite inoculum, and parasite intradermal
delivery.
Female BALB/c and B10D2 mice were purchased from Harlan
(Gannat, France) and used for infection at 6 to 8 weeks of age.
L. major strain NIH 173 (MHOM/IR/-/173) was cultured at
26°C in Hosmem-II medium (7) supplemented with 10%
heat-inactivated fetal calf serum (Dutscher, Brumath, France), 100 U of
penicillin per ml, and 100 µg of streptomycin (Seromed, Berlin,
Germany) per ml.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Leishmania major Reaches Distant Cutaneous Sites Where
It Persists Transiently while Persisting Durably in the Primary Dermal
Site and Its Draining Lymph Node: a Study with Laboratory
Mice

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
), and
iNOS but not IL-10 transcripts in these inoculated ears and draining
lymph nodes of long-term-infected mice, either resistant (B10D2) or
susceptible (BALB/c), paralleled the parasite burden. As far as the
parasite transmission from the vertebrate host to the vector is
concerned, the most notable finding from these studies is that early
transient dissemination via the blood does allow parasites to reach
other distant dermal sites such as the contralateral ear and tail skin,
two sites where they persist at a low level for at least 3 months. The
next step will be to determine whether these Leishmania
parasites residing in these clinically silent tissues are transmissible
and will be indeed taken up by the sandflies from these otherwise
accessible dermal sites.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
thickness of uninoculated ear).
Tissue sampling for monitoring parasite burden by PCR.
At
week 2 and months 1, 3, 6, 8, and 12 postinfection, 3 to 10 mice were
killed at each time point for monitoring the distribution of the
parasites in the different tissues, using a quantitative PCR assay.
Blood was sampled at the retroorbital sinus, prior to the killing of
the animals, and was kept in EDTA (0.1 M). The following tissues were
sampled: retromaxillar draining lymph nodes, spleen, liver, both ears
separately, bone marrow from the two femurs, and a piece of tail skin.
Tissues were removed by using different scissors or scalpels to avoid
contamination and were minced with Potter grinders and then carefully
homogenized in 1.5-ml microtubes with single-use blue pellet pestles
(Polylabo, Paris, France) in PBS. Aliquots of the homogenates were
stored at
20°C until DNA extraction.
DNA extraction. DNA was isolated from the tissue homogenates using the InstaGene DNA purification matrix (Bio-Rad, Ivry s/Seine, France). Homogenates (50 µl) were mixed with 200 µl of DNA purification matrix, incubated for 45 min at 56°C and 8 min at 98°C, and then centrifuged at 10,000 × g for 5 min. DNA from blood samples was purified from 50 µl aliquots using the InstaGene Whole Blood purification kit (Bio-Rad). Samples of the supernatants (2 µl) were used for PCR analysis.
PCR amplification. Specific detection of Leishmania DNA was carried out using the primers forward, 5'-CCTATTTTACACCAACCCCCAGT-3'(JW11), and reverse, 5'-GGGTAGGGGCGTTCTGCGAAA-3' (JW12), which amplify a 116-bp fragment of the minicircle kinetoplast DNA (kDNA) of L. major, present at ca. 10,000 copies in each parasite (4, 11). Extracted DNA (2 µl) was mixed with a solution containing 10 mM Tris-HCl (pH 9.0), 50 mM KCl, 0.1% Triton X-100, 2 mM MgCl2, a 250 µM concentration of each deoxynucleotide triphosphate, 10 pmol of each primer, and 0.5 U of Taq polymerase (Promega, Charbonnières, France), in a 40-µl final volume. PCR was performed with an automated thermocycler (PCR-Express; Hybaid, Ashford, United Kingdom), with which the annealing temperature was optimized from 48 to 60°C. A hot-start procedure was used to increase specificity. After an initial denaturation (4 min at 94°C), 30 cycles (denaturation for 1 min at 64°C, annealing for 30 s at 58°C, elongation for 30 s at 72°C) were carried out and PCR was terminated by a final extension at 72°C for 10 min. Each sample was tested in duplicate. Negative control tubes which received 2 µl of water instead of DNA extract were included in each run of PCR to detect any amplicon contamination.
Sensitivity and reproducibility of the PCR based assay of kDNA of L. major. The reproducibility of extraction of Leishmania DNA from the different tissues and the impact of putative PCR inhibitory processes were evaluated with mimics of infected tissues. Homogenates from different tissues, or PBS as a control, were spiked with 10-fold increasing numbers of L. major promastigotes, extracted in duplicate and subjected to PCR with Leishmania specific primers. PCR products were quantified from ethidium bromide-stained agarose gels and scanned with ImageQuant for Windows. An internal standard was loaded on each gel.
Quantitative PCR by dilution limits. For tissues highly infected, DNA was extracted from serial dilutions of homogenates, and six replicates of each dilution were subjected to PCR. The number of parasites in each tissue was determined from the highest dilution at which Leishmania DNA could be detected by PCR.
Quantification of iNOS, IL-4, IL-10, and IFN-
transcripts.
At months 8 and 12 postinfection, whole ears,
retromaxillar lymph nodes, and a piece of tail skin were collected, and
the transcripts of iNOS, IL-4, IL-10, and IFN-
were quantified by competitive reverse transcription-PCR as described in reference 12. Briefly, total RNA was isolated using the RNeasy
kit (Qiagen, Hilden, Germany) and reverse transcribed. Reverse
transcripts (cDNA) were quantified using a PCR method involving
coamplification of cDNA with an internal standard. The standards were
generated by addition of 2 to 4 bp to the sequence of the wild-type DNA molecules, which generated restriction sites specific for either wild-type or standard DNAs. After restriction endonuclease digestion, the equivalence between coamplified cDNA and standard DNA was monitored
on agarose gel. To eliminate variations due to RNA extraction and cDNA
synthesis steps, quantification of each transcript in a given sample
was expressed with respect to a constant number (106) of
-actin copies.
| |
RESULTS |
|---|
|
|
|---|
Monitoring of the symptoms at the inoculation site, the right
ear.
When 104 L. major NIH 173 metacyclic
promastigotes were inoculated into the ear dermis, the dermal lesions
were first detectable around week 3 in mice of both inbred lines (Fig.
1). In BALB/c mice, the increase of
thickness was higher than that in B10D2 mice, peaked around week 5, and
was followed by tissue necrosis and loss of tissue around week 6 and
onwards, leaving clean scars. Of note, in a few BALB/c mice, necrosis
was never observed up to 12 months. In B10D2 mice, the thickness of the
inoculated ear peaked around week 5 as well and then declined slowly.
The thickness of contralateral noninoculated ears remained constant
throughout the experiment, and no external clinical symptoms were
observed.
|
Detection and quantitation of Leishmania DNA:
reproducibility and sensitivity of PCR.
The putative impact of
tissue origin on PCR yield when amplifying Leishmania target
kDNA was checked with tissue homogenates from naïve BALB/c or
B10D2 mice spiked with known numbers of in vitro-grown L. major promastigotes. After 30 cycles of amplification, parasite
concentrations ranging from 102 to 105 per ml
of tissue homogenate were detectable in a linear way, i.e., 5 to 5 × 103 parasites per DNA extract in a 50-µl sample and
the origin of tissue did not significantly influence the yield of PCR,
except when parasites were recovered from blood, which led to a lower number of amplicon molecules (Fig. 2).
All the tissue homogenates from naïve mice were PCR negative
with the Leishmania specific primers used, even after 40 cycles of PCR. For a given tissue, the reproducibility of
Leishmania DNA extraction was checked (not shown). Under the
experimental conditions used, the thresholds of detection levels,
after 30 cycles of amplification, were approximately 20 parasites/ml of blood, 10 parasites/femoral bone marrow or lymph node,
20 parasites/ear, 40 parasites/piece of tail, and 100 parasites/spleen
or liver.
|
|
|
L. major does persist durably in the inoculation site
and its draining lymph node, but is there a unique profile of IL-4,
IFN-
, iNOS, and IL-10 transcripts in both sites?
The parasite
burden in the site of inoculation (right ear), followed a similar
pattern in BALB/c and B10D2 mice, with a peak at month 1 followed by a
decrease until month 12 (Fig. 3). However, in susceptible mice
(BALB/c), the estimated numbers of parasites remained approximately 10 times higher than that in resistant mice, despite the fact that in the
inoculated ear of BALB/c mice there was a loss of tissue from month 3 onwards. In resistant mice, the mean numbers of parasites remaining at
the site of inoculation were nevertheless estimated at ca.
103 parasites at month 6 and were still 102 at
month 12. The parasite numbers in noninoculated left ears were similar
in both mouse inbred lines and never exceeded ca. 103
parasites per ear until month 3. In contrast to what happened in the
ears, the estimated parasite numbers in the retromaxillar lymph node
draining the inoculated right ear, rapidly increased in BALB/c and
B10D2 mice until month 3. However, in susceptible BALB/c mice, the
numbers of parasites reached a plateau of ca. 107 parasites
per node, while a sharp decrease was observed in resistant mice.
, and iNOS were quantified in
long-term-infected mice at months 8 and 12 in the ears and in the
retromaxillar lymph nodes and at month 8 only in a piece of the tail
skin (Fig. 4). In BALB/c mice, the levels
of the transcripts of IL-4, IFN-
, IL-10, and iNOS at month 8 were
significantly higher in the inoculated site (right ear)
(P < 0.004) and its draining lymph node
(P < 0.01) than in respective contralateral tissues.
The levels of transcripts in left ears and their draining lymph nodes
were similar to those observed in tail skins, which are close to the
levels measured in the skin of naïve BALB/c mice (J. H. Colle, unpublished data). At month 12, the levels of transcripts in the
different tissues were not significantly different than at month 8, except for IL-4 in the inoculation site (right ear) and its draining
lymph node (right lymph node), where the levels of transcripts
significantly decreased between months 8 and 12 (P < 0.01).
|
and iNOS transcripts were
slightly higher in the right ears and draining lymph node than in the
respective contralateral tissue. However, this slight difference was
only statistically significant for ears. Globally, when BALB/c and
B10D2 mice are compared, the levels of IL-4, IFN-
, and iNOS
transcripts were higher in infected ears and their draining lymph nodes
of BALB/c than in those of B10D2 mice (P < 0.004, for
IL-4 and IFN-
in right lymph node). Special attention must be drawn
to IL-10: the levels of this transcript remained higher in infected
ears and their draining lymph nodes than in contralateral tissues, in
mice of both lines. In tail skin, the levels of all transcripts were
close to that observed at homeostasis, whatever the mouse lines. In
B10D2 mice, the levels of all transcripts did not significantly vary
between months 8 and 12, in the different tissues.
Presence of a stable number of parasites over 3 to 6 months in distant cutaneous sites: a clinically silent transient process. Two weeks after inoculation, the first time point we selected in the present study, Leishmania DNA was detected in the site of inoculation and its draining lymph node in all mice analyzed but also was detected in distant tissues such as the noninoculated ear (left ear), tail skin, and blood in most of mice, which indicated at least the transient presence of parasites in the blood (Table 1). Parasite load in those organs remained stable and low (~103/contralateral ear), and no parasite DNA was recovered after month 3 in blood and contralateral ears and after month 6 in tail skins, whatever the mouse line (Table 1). Detection of DNA in liver and bone marrow was sporadic in both mouse lines and never exceeded 5,000 parasites per liver and 50 parasites per femur bone marrow. All the spleens of BALB/c mice were PCR positive until month 3, and five out of nine were PCR positive at month 6; however, the parasite burden in this organ remained low (<500 parasites per spleen). In contrast, the spleens of B10D2 mice were parasite DNA negative.
It is important to note that no clinical symptoms were detected over the period of observation (12 months).| |
DISCUSSION |
|---|
|
|
|---|
In this work is compared, for the first time, the extent and duration of the multifocal distribution of L. major disseminating from the dermal site where they were initially delivered. Following intradermal delivery of 104 L. major metacyclic promastigotes in one ear, parasite presence and load were estimated in the draining lymph nodes, the blood, the blood-filtering tissues, and distant cutaneous sites, such as the contralateral ear and the tail skin.
In terms of clinical symptoms in the different cutaneous sites loaded with or reached by the parasites, the only sites where symptoms develop until tissue destruction, with clean scars, are the inoculated ears of BALB/c mice. In the inoculated ears of B10D2 mice, a transient lesion was observed which healed without loss of tissue and without scar or with a minimal fibrotic scar. In all other cutaneous tissues which were reached by parasites, i.e., the contralateral ears and tail skin, no clinical symptom was observed.
If data on the mouse immunological determinants of the early steps of
infection
following subcutaneous inoculation of large number of
stationary phase promastigotes
are now well established (14,
20), data on the late steps of this long term process are still
lacking, especially when parasites have been delivered intradermally.
In this study we have analyzed the amounts of transcripts of IL-4,
IL-10, IFN-
, and iNOS in 8- and 12-month-infected mice. Globally at
month 8, except for IL-10, we have observed that the levels of those
transcripts are related to the parasite load and long-term persistence,
especially in the lymph node of BALB/c mice where ~107
parasites persist. Similar features have been noticed when biopsy specimens of human patients infected by L. major in Tunisia
have been monitored for the same transcripts plus IL-12 transcripts: a
positive association between IL-12 and IFN-
transcripts and the
presence of parasites in the lesion was pinpointed (17). These authors have also observed that the biopsy specimens of the
patients exhibiting a higher level of IL-10, IL-12, and IFN-
transcripts had an unfavorable evolution of the lesion. In the present study, at month 12, the overall transcript profile did not dramatically change even if the parallel fluctuations of IFN-
, IL-10, and iNOS transcripts are notable in the lymph node of
BALB/c mice, where the parasites persist at a very high level.
The most notable finding from this study is the rapid and multifocal distribution of the parasites in the mouse body after intradermal inoculation of 104 NIH 173 metacyclic promastigotes, which followed a similar pattern in mice of both inbred lines. Rapid and at least transient distribution of the parasites was observed in the blood compartment and in hairless cutaneous sites distant from the inoculation site, such as the tail skin or the contralateral ear. However, in contrast to study using different routes of inoculation with large doses of parasites, the liver, spleen, and femoral bone marrow of either BALB/c or B10D2 mice remained sporadically parasitized in this study. Therefore, particular attention should be paid to the route of parasite delivery in model studies, to mimic as much as possible the natural situation (6).
It remains now to be determined (i) whether the parasites which circulate and reach cutaneous distant tissue are free or intracellular and if so, which leukocyte subsets act as shuttles (phagocytic mononuclear cells or dendritic leukocytes are relevant candidates); (ii) whether the parasites are transported directly via the venous or indirectly via the lymphatic network; and (iii) in these distant cutaneous tissues, what local immunological and nonimmunological features allow the transient persistence (0.5 to 3 months) of a stable number of parasites while their number increases in the inoculated sites and DLN during the same period at least in BALB/c mice.
The cutaneous tissues distant from the inoculation site, e.g., contralateral ears or tail skin, remained parasitized for 3 to 5 months after initial infection not only in mice with destructive lesions but also in mice which were able to control the lesions. This indicates that most of these mice probably remain, during this period, efficient reservoirs for transmission to sandflies, even in absence of reinfection, which should be checked by feeding sandflies on long-term-infected mice. This also emphasizes the interest of further studies in field situations as well to determine the presence of Leishmania in the lesion-face skin of putative reservoir hosts, at least rodents. The large range of PCR primers now available to accurately detect the presence of Leishmania DNA should facilitate such epidemiological studies (2, 8, 22).
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by grants from the Délégation Générale pour l'Armement (contract DGA 95/150) and from the Institut Pasteur. S. Sidjanski received a fellowship from Hoffmann-Laroche Foundation and Novartis Foundation.
We thank Nathalie Courret for providing Leishmania metacyclic promastigotes and Karim Sebastien for taking care of the mice used in this study.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institut Pasteur, Unité d'Immunophysiologie et Parasitisme Intracellulaire, 25 rue du Dr Roux, 75724 Paris Cedex 15, France. Phone: (33) 1 45 68 81 70. Fax: (33) 1 40 61 31 69. E-mail: lnicolas{at}pasteur.fr.
Present address: Research Policy and Cooperation, World Health
Organization, Geneva, Switzerland.
Editor: J. M. Mansfield
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Aebischer, T. 1994. Recurrent cutaneous leishmaniasis: a role for persistent parasites. Parasitol. Today 10:25-28[Medline]. |
| 2. | Alexander, B., C. Lozano, D. C. Barker, S. H. E. McCann, and G. H. Adler. 1998. Detection of Leishmania (Viannia) braziliensis complex in wild mammals from colombian coffee plantations by PCR and DNA hybridization. Acta Trop. 69:41-50[CrossRef][Medline]. |
| 3. | Alvar, J., C. Canavate, B. Gutierrez-Solar, M. Jimenez, F. Laguna, R. Lopez-Velez, R. Molina, and J. Moreno. 1997. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin. Microbiol. Rev. 10:298-319[Abstract]. |
| 4. | Barker, D. C., L. J. Gibson, W. P. K. Kennedy, A. A. A. A. Nasser, and R. H. Williams. 1986. The potential of using recombinant DNA species specific probes for the identification of tropical Leishmania. Parasitology 91(Suppl.):S139-S174. |
| 5. | Belkaid, Y., H. Jouin, and G. Milon. 1996. A method to recover, enumerate and identify lymphomyeloid cells present in an inflammatory dermal site: a study in laboratory mice. J. Immunol. Methods 199:5-25[CrossRef][Medline]. |
| 6. |
Belkaid, Y.,
S. Kamhawi,
G. Modi,
J. Valenzuela,
N. Noben-Trauth,
E. Rowton,
J. Riberio, and D. L. Sacks.
1998.
Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis.
J. Exp. Med.
188:1941-1953 |
| 7. | Berens, R. L., and J. J. Marr. 1978. An easily prepared defined medium for cultivation of Leishmania donovani promastigotes. J. Parasitol. 64:160[CrossRef][Medline]. |
| 8. | Berrahal, F., C. Mary, M. Roze, A. Berenger, K. Escoffier, D. Lamouroux, and S. Dunan. 1996. Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting. Am. J. Trop. Med. Hyg. 55:273-277. |
| 9. | Bogdan, C., A. Gessner, W. Solbach, and M. Röllinghoff. 1996. Invasion, control and persistence of Leishmania parasites. Curr. Opin. Immunol. 8:517-525[CrossRef][Medline]. |
| 10. | Bogdan, C., and M. Röllinghoff. 1999. How do protozoan parasites survive inside macrophages. Parasitol. Today 15:22-28[CrossRef][Medline]. |
| 11. | Brewster, S., M. Aslett, and D. C. Barker. 1998. Kinetoplast DNA minicircle database. Parasitol. Today 14:437-438. |
| 12. | Colle, J. H., P. B. Falanga, M. Singer, B. Hevin, and G. Milon. 1997. Quantitation of messenger RNA by competitive RT-PCR: a simplified read out assay. J. Immunol. Methods 210:175-184[CrossRef][Medline]. |
| 13. | Courret, N., E. Prina, E. Mougneau, E. M. Saraiva, D. L. Sacks, N. Glaichenhaus, and J. C. Antoine. 1999. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites. Eur. J. Immunol. 29:762-773[CrossRef][Medline]. |
| 14. | Launois, P., J. A. Louis, and G. Milon. 1997. The fate and persistence of Leishmania major in mice of different genetic backgrounds: an example of exploitation of the immune system by intracellular parasites. Parasitology 115:S25-S32. |
| 15. | Leclercq, V., M. Lebastard, Y. Belkaid, J. Louis, and G. Milon. 1996. The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the Lsh and MHC loci. J. Immunol. 157:4537-4545[Abstract]. |
| 16. |
Le Fichoux, Y.,
J. F. Quaranta,
J. P. Aufeuvre,
A. Lelièvre,
P. Marty,
I. Suffia,
D. Rousseau, and J. Kubar.
1999.
Occurrence of Leishmania infantum in asymptomatic blood donors living in an area of endemicity in Southern France.
J. Clin. Microbiol.
37:1953-1957 |
| 17. | Louzir, H., P. C. Melby, A. Ben Salah, H. Marrakchi, K. Aoun, R. Ben Ismail, and K. Dellagi. 1998. Immunological determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major. J. Infect. Dis. 177:1687-1695[Medline]. |
| 18. |
Melby, P. C.,
Y. Z. Yang,
J. Cheng, and W. Zhao.
1998.
Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani.
Infect. Immun.
66:18-27 |
| 19. | Sacks, D. L., S. Hieny, and A. Sher. 1985. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. J. Immunol. 135:564-569[Abstract]. |
| 20. | Solbach, W., and T. Laskay. 2000. The host response to Leishmania infection. Adv. Immunol. 74:275-317[Medline]. |
| 21. |
Stenger, S.,
N. Donhauser,
H. Thüring,
M. Röllinghof, and C. Bogdan.
1996.
Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase.
J. Exp. Med.
183:1501-1514 |
| 22. | Telleria, J., M. F. Bosseno, T. Tarifa, R. Buitrago, E. Martinez, M. Torrez, F. Le Pont, and S. F. Brenière. 1999. Putative reservoirs of Leishmania amazonensis in a sub-andean focus of Bolivia identified by kDNA polymerase chain reaction. Mem. Inst. Oswaldo Cruz 94:5-6[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|